Stefan Knapp

48.5k total citations · 4 hit papers
516 papers, 29.0k citations indexed

About

Stefan Knapp is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Stefan Knapp has authored 516 papers receiving a total of 29.0k indexed citations (citations by other indexed papers that have themselves been cited), including 410 papers in Molecular Biology, 121 papers in Oncology and 64 papers in Organic Chemistry. Recurrent topics in Stefan Knapp's work include Protein Degradation and Inhibitors (129 papers), Ubiquitin and proteasome pathways (71 papers) and Protein Kinase Regulation and GTPase Signaling (50 papers). Stefan Knapp is often cited by papers focused on Protein Degradation and Inhibitors (129 papers), Ubiquitin and proteasome pathways (71 papers) and Protein Kinase Regulation and GTPase Signaling (50 papers). Stefan Knapp collaborates with scholars based in Germany, United Kingdom and United States. Stefan Knapp's co-authors include P. Filippakopoulos, Susanne Müller, O. Fedorov, A. Chaikuad, Alex N. Bullock, Rudolf Ladenstein, S. Picaud, J.E. Debreczeni, Paul E. Brennan and Jonathan M. Elkins and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Stefan Knapp

504 papers receiving 28.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family

2012 1.2k citations P. Filippakopoulos, Susanne Müller et al. profile →
Targeting bromodomains: epigenetic readers of lysine acetylation

2014 957 citations P. Filippakopoulos, Stefan Knapp profile →
Trends in kinase drug discovery: targets, indications and inhibitor design

2021 510 citations Stefan Knapp et al. profile →
Copper is required for oncogenic BRAF signalling and tumorigenesis

2014 487 citations A. Chaikuad, Stefan Knapp et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Stefan Knapp	21.6k	5.6k	3.9k	3.7k	2.3k	516	29.0k
Nathanael S. Gray	30.5k 1.4×	10.9k 2.0×	3.4k 0.9×	5.0k 1.4×	4.0k 1.7×	476	42.2k
Shaomeng Wang	20.8k 1.0×	7.0k 1.3×	1.8k 0.5×	5.4k 1.5×	1.1k 0.5×	459	29.3k
John Kuriyan	28.8k 1.3×	7.0k 1.3×	3.9k 1.0×	2.0k 0.6×	4.9k 2.1×	235	38.8k
Stephen W. Fesik	24.8k 1.1×	5.3k 1.0×	1.0k 0.3×	3.1k 0.8×	2.2k 1.0×	267	31.1k
Edward A. Sausville	19.3k 0.9×	11.7k 2.1×	2.1k 0.5×	2.7k 0.8×	3.0k 1.3×	329	30.9k
Ting‐Chao Chou	14.1k 0.7×	8.1k 1.4×	1.6k 0.4×	4.2k 1.2×	1.4k 0.6×	350	29.3k
Neal Rosen	24.7k 1.1×	12.2k 2.2×	1.0k 0.3×	2.0k 0.5×	2.4k 1.0×	255	34.8k
Paul Workman	18.6k 0.9×	5.8k 1.0×	712 0.2×	2.7k 0.8×	2.3k 1.0×	535	27.7k
Giulio Superti‐Furga	13.5k 0.6×	2.9k 0.5×	3.1k 0.8×	1.1k 0.3×	2.1k 0.9×	247	21.7k
Alexander Levitzki	14.3k 0.7×	5.9k 1.1×	1.4k 0.4×	1.7k 0.5×	2.2k 1.0×	328	22.3k

Countries citing papers authored by Stefan Knapp

Since Specialization

Citations

This map shows the geographic impact of Stefan Knapp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Knapp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Knapp more than expected).

Fields of papers citing papers by Stefan Knapp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Knapp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Knapp. The network helps show where Stefan Knapp may publish in the future.

Co-authorship network of co-authors of Stefan Knapp

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Knapp. A scholar is included among the top collaborators of Stefan Knapp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Knapp. Stefan Knapp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Meyners, Christian, Edvaldo Vasconcelos Soares Maciel, Thomas Geiger, et al.. (2025). Discovery of fully synthetic FKBP12-mTOR molecular glues. Chemical Science. 16(10). 4256–4263. 12 indexed citations

Krämer, Andreas, Stefan Knapp, Catherine Dunyach‐Remy, et al.. (2025). Targeting bacterial kinases as a strategy to counteract antibiotic resistance. Communications Chemistry. 8(1). 390–390. 1 indexed citations

Kimani, Serah, Martin P. Schwalm, H. Holzmann, et al.. (2025). Discovery of an exquisitely selective WDR5 chemical probe accelerated by a high-quality DEL–ML Hit. RSC Chemical Biology. 6(10). 1585–1594. 1 indexed citations

Rudalska, Ramona, Martin P. Schwalm, B.J. Wagner, et al.. (2024). Development of Highly Potent and Selective Covalent FGFR4 Inhibitors Based on S _N Ar Electrophiles. Journal of Medicinal Chemistry. 67(8). 6549–6569. 14 indexed citations

Warwick, Timothy, Stefan Günther, Sebastian Wolf, et al.. (2024). RUNX1 interacts with lncRNA SMANTIS to regulate monocytic cell functions. Communications Biology. 7(1). 1131–1131. 4 indexed citations

Krämer, Andreas, Tran Do Hoang Nhu, Andreas C. Joerger, et al.. (2024). Back-Pocket Optimization of 2-Aminopyrimidine-Based Macrocycles Leads to Potent EPHA2/GAK Kinase Inhibitors. Journal of Medicinal Chemistry. 67(15). 12534–12552. 8 indexed citations

Hu, Huabin, et al.. (2023). A machine learning and live-cell imaging tool kit uncovers small molecules induced phospholipidosis. Cell chemical biology. 30(12). 1634–1651.e6. 5 indexed citations

Schwalm, Martin P., Stefan Knapp, & Vladimir V. Rogov. (2023). Toward effective Atg8‐based ATTECs: Approaches and perspectives. Journal of Cellular Biochemistry. 125(11). e30380–e30380. 3 indexed citations

Strubel, Alexander, Oliver Hartmann, A. Chaikuad, et al.. (2023). DARPins detect the formation of hetero-tetramers of p63 and p73 in epithelial tissues and in squamous cell carcinoma. Cell Death and Disease. 14(10). 674–674. 7 indexed citations

10.

Reimer, Janice M., Andrea M. Dickey, Robert G. Abrisch, et al.. (2023). Structure of LRRK1 and mechanisms of autoinhibition and activation. Nature Structural & Molecular Biology. 30(11). 1735–1745. 6 indexed citations

11.

Tallant, C., Katarzyna B. Leszczyńska, Rachel L. Grimley, et al.. (2022). Identification of Histone Peptide Binding Specificity and Small-Molecule Ligands for the TRIM33α and TRIM33β Bromodomains. ACS Chemical Biology. 17(10). 2753–2768. 13 indexed citations

12.

Schmidt, Sven H., Jui‐Hung Weng, Phillip C. Aoto, et al.. (2021). Conformation and dynamics of the kinase domain drive subcellular location and activation of LRRK2. Proceedings of the National Academy of Sciences. 118(23). 38 indexed citations

13.

Lyczek, Agatha, Benedict‐Tilman Berger, Steven K. Albanese, et al.. (2021). Mutation in Abl kinase with altered drug-binding kinetics indicates a novel mechanism of imatinib resistance. Proceedings of the National Academy of Sciences. 118(46). 40 indexed citations

14.

Chaikuad, A., Sebastian E. Koschade, Alexandra Stolz, et al.. (2019). Conservation of structure, function and inhibitor binding in UNC-51-like kinase 1 and 2 (ULK1/2). Biochemical Journal. 476(5). 875–887. 43 indexed citations

15.

Kashima, Risa, Patrick Redmond, Sougata Roy, et al.. (2017). Hyperactive locomotion in a Drosophila model is a functional readout for the synaptic abnormalities underlying fragile X syndrome. Science Signaling. 10(477). 32 indexed citations

16.

Chang, Audrey N., P. Mahajan, Stefan Knapp, et al.. (2016). Cardiac myosin light chain is phosphorylated by Ca ²⁺ /calmodulin-dependent and -independent kinase activities. Proceedings of the National Academy of Sciences. 113(27). E3824–33. 43 indexed citations

17.

Ma, Yufang, Lihong Wang, Leif R. Neitzel, et al.. (2016). The MAPK Pathway Regulates Intrinsic Resistance to BET Inhibitors in Colorectal Cancer. Clinical Cancer Research. 23(8). 2027–2037. 56 indexed citations

18.

Hammitzsch, Ariane, C. Tallant, O. Fedorov, et al.. (2015). CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses. Proceedings of the National Academy of Sciences. 112(34). 10768–10773. 195 indexed citations

19.

Cheng, Zhixiang, Yuanying Gong, Yufang Ma, et al.. (2013). Inhibition of BET Bromodomain Targets Genetically Diverse Glioblastoma. Clinical Cancer Research. 19(7). 1748–1759. 233 indexed citations

20.

Pogačić, Vanda, Alex N. Bullock, O. Fedorov, et al.. (2007). Structural Analysis Identifies Imidazo[1,2- b ]Pyridazines as PIM Kinase Inhibitors with In vitro Antileukemic Activity. Cancer Research. 67(14). 6916–6924. 169 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact